Transglutaminase is a mesothelioma cancer stem cell survival protein that is required for tumor formation.

Adhikary G, Grun D, Alexander HR, Friedberg JS, Xu W, Keillor JW, Kandasamy S, Eckert RL

Open source

DOI
10.18632/oncotarget.26130
Published
2018 Oct 2
Container
Oncotarget
Publisher
Not recorded
Open access
yes

Credibility signals

serious concern Score 10/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.18632/oncotarget.26130,
  title = {Transglutaminase is a mesothelioma cancer stem cell survival protein that is required for tumor formation.},
  author = {Adhikary G and Grun D and Alexander HR and Friedberg JS and Xu W and Keillor JW and Kandasamy S and Eckert RL},
  year = {2018},
  journal = {Oncotarget},
  doi = {10.18632/oncotarget.26130},
  url = {https://doi.org/10.18632/oncotarget.26130}
}

RIS

TY  - JOUR
TI  - Transglutaminase is a mesothelioma cancer stem cell survival protein that is required for tumor formation.
AU  - Adhikary G
AU  - Grun D
AU  - Alexander HR
AU  - Friedberg JS
AU  - Xu W
AU  - Keillor JW
AU  - Kandasamy S
AU  - Eckert RL
PY  - 2018
JO  - Oncotarget
DO  - 10.18632/oncotarget.26130
UR  - https://doi.org/10.18632/oncotarget.26130
ER  - 

APA

G, A., D, G., HR, A., JS, F., W, X., JW, K., S, K., & RL, E. (2018). Transglutaminase is a mesothelioma cancer stem cell survival protein that is required for tumor formation.. Oncotarget. https://doi.org/10.18632/oncotarget.26130

Source records